Drugs / Lyophilized powder from edible mushrooms
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07806279 | Oct 2026 → Dec 2030 expected | metabolic syndrome X, obesity disorder | Uppsala University | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lyophilized powder from edible mushrooms | “Participants randomized to the treatment arms receiving the lyophilized powder from edible mushrooms will be instructed to consume it as part of their daily diet.” NCT07806279 ↗ |